REAL-WORLD OUTCOMES IN PATIENTS WITH PENILE SQUAMOUS CELL CARCINOMA (PSCC) RECEIVING IMMUNE CHECKPOINT INHIBITORS (ICI)

被引：2
|
作者：
Zhuang, Tony [1 ]
Goyal, Subir [1 ]
Brown, Jacqueline [1 ]
Carthon, Bradley [1 ]
Kucuk, Omer [1 ]
McClintock, Greta [1 ]
Yantorni, Lauren [1 ]
Bilen, Mehmet [1 ]
Master, Viraj [1 ]
Nazha, Bassel [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷
关键词：
D O I：
10.1136/jitc-2022-SITC2022.0478
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
478
引用
收藏
页码：A498 / A499
页数：2
相关论文
共 50 条
  • [1] Association of baseline inflammatory biomarkers with outcomes in penile squamous cell carcinoma (pSCC) treated with immune checkpoint inhibitors (ICI).
    Zhuang, Tony
    Goyal, Subir
    Brown, Jacqueline T.
    Carthon, Bradley Curtis
    Kucuk, Omer
    McClintock, Greta Russler
    Yantorni, Lauren Beth
    Bilen, Mehmet Asim
    Master, Viraj A.
    Nazha, Bassel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Hanna, Glenn J.
    Ruiz, Emily S.
    LeBoeuf, Nicole R.
    Thakuria, Manisha
    Schmults, Chrysalyne D.
    Decaprio, James A.
    Silk, Ann W.
    [J]. BRITISH JOURNAL OF CANCER, 2020, 123 (10) : 1535 - 1542
  • [3] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Glenn J. Hanna
    Emily S. Ruiz
    Nicole R. LeBoeuf
    Manisha Thakuria
    Chrysalyne D. Schmults
    James A. Decaprio
    Ann W. Silk
    [J]. British Journal of Cancer, 2020, 123 : 1535 - 1542
  • [4] Real-world experience and outcomes of immune-checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC)
    Paul, Samuel
    Min, Eric
    Benson, Katherine K.
    Xu, Menglin
    Noonan, Anne M.
    Mittra, Arjun
    Malalur, Pannaga G.
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Elkhatib, Rifat T.
    Rahman, Shafia
    Miller, Eric David
    Pardo, Dayssy Alexandra Diaz
    Manne, Ashish
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] A real-world experience of immune checkpoint inhibitors (ICI) in metastatic renal cell carcinoma (mRCC)
    Elias, Roy
    Levonyak, Nicholas
    Christie, Alana
    Bowman, Isaac Alexander
    Kapur, Payal
    Hannan, Raquibul
    Hammers, Hans J.
    Brugarolas, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [6] Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence
    Hein, Erica C. Koch
    Vilbert, Maysa
    Hirsch, Ian
    Ribeiro, Mauricio Fernando
    Mantle, Luke
    Fournier, Cynthia
    Butler, Marcus O.
    Spreafico, Anna
    Saibil, Samuel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
    Luke S. McLean
    Annette M. Lim
    Mathias Bressel
    Alesha A. Thai
    Danny Rischin
    [J]. Drugs & Aging, 2024, 41 : 271 - 281
  • [8] Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
    McLean, Luke S.
    Lim, Annette M.
    Bressel, Mathias
    Thai, Alesha A.
    Rischin, Danny
    [J]. DRUGS & AGING, 2024, 41 (03) : 271 - 281
  • [9] Real-world outcomes among US Merkel cell carcinoma patients initiating immune checkpoint inhibitors or chemotherapy
    Chandra, Sunandana
    Zheng, Ying
    Pandya, Shivani
    Yu, Ting
    Kearney, Mairead
    Wang, Li
    Kim, Ruth
    Phatak, Hemant
    [J]. FUTURE ONCOLOGY, 2020, 16 (31) : 2521 - 2536
  • [10] Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Kato, Taigo
    Nagahara, Akira
    Kawamura, Norihiko
    Nakata, Wataru
    Soda, Tetsuji
    Matsuzaki, Kyosuke
    Hatano, Koji
    Kawashima, Atsunari
    Ujike, Takeshi
    Imamura, Ryoichi
    Nishimura, Kensaku
    Takada, Shingo
    Tsujihata, Masao
    Yamaguchi, Seiji
    Takao, Tetsuya
    Nakai, Yasutomo
    Nakayama, Masashi
    Nonomura, Norio
    Uemura, Motohide
    [J]. ANTICANCER RESEARCH, 2021, 41 (11) : 5811 - 5816
12345